Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Other Accumulated Expenses (2021 - 2025)

Historic Other Accumulated Expenses for Nutex Health (NUTX) over the last 5 years, with Q3 2025 value amounting to $64.3 million.

  • Nutex Health's Other Accumulated Expenses rose 11662.48% to $64.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $64.3 million, marking a year-over-year increase of 11662.48%. This contributed to the annual value of $47.7 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Nutex Health's Other Accumulated Expenses stood at $64.3 million, which was up 11662.48% from $68.8 million recorded in Q2 2025.
  • In the past 5 years, Nutex Health's Other Accumulated Expenses registered a high of $127.2 million during Q1 2025, and its lowest value of $6.2 million during Q4 2022.
  • Over the past 5 years, Nutex Health's median Other Accumulated Expenses value was $17.7 million (recorded in 2024), while the average stood at $33.0 million.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 7362.22% in 2022, then skyrocketed by 61870.71% in 2025.
  • Nutex Health's Other Accumulated Expenses (Quarter) stood at $6.9 million in 2021, then dropped by 9.08% to $6.2 million in 2022, then surged by 136.72% to $14.8 million in 2023, then soared by 223.16% to $47.7 million in 2024, then skyrocketed by 34.71% to $64.3 million in 2025.
  • Its Other Accumulated Expenses stands at $64.3 million for Q3 2025, versus $68.8 million for Q2 2025 and $127.2 million for Q1 2025.